439 related articles for article (PubMed ID: 33051104)
1. A Cytokine Circus with a Viral Ringleader: SARS-CoV-2-Associated Cytokine Storm Syndromes.
Cabler SS; French AR; Orvedahl A
Trends Mol Med; 2020 Dec; 26(12):1078-1085. PubMed ID: 33051104
[TBL] [Abstract][Full Text] [Related]
2. The emergence of a new cytokine storm during the COVID-19 pandemic: Multisystem inflammatory syndrome in children.
Yang MC; Tsai CC; Su YT; Wu JR
Kaohsiung J Med Sci; 2021 Mar; 37(3):255-256. PubMed ID: 33400372
[No Abstract] [Full Text] [Related]
3. Age-related differences in the immune response could contribute to determine the spectrum of severity of COVID-19.
Costagliola G; Spada E; Consolini R
Immun Inflamm Dis; 2021 Jun; 9(2):331-339. PubMed ID: 33566457
[TBL] [Abstract][Full Text] [Related]
4. Lessons learned: new insights on the role of cytokines in COVID-19.
Buszko M; Nita-Lazar A; Park JH; Schwartzberg PL; Verthelyi D; Young HA; Rosenberg AS
Nat Immunol; 2021 Apr; 22(4):404-411. PubMed ID: 33723418
[TBL] [Abstract][Full Text] [Related]
5. Similarities and differences between the immunopathogenesis of COVID-19-related pediatric multisystem inflammatory syndrome and Kawasaki disease.
Esteve-Sole A; Anton J; Pino-Ramirez RM; Sanchez-Manubens J; Fumadó V; Fortuny C; Rios-Barnes M; Sanchez-de-Toledo J; Girona-Alarcón M; Mosquera JM; Ricart S; Launes C; de Sevilla MF; Jou C; Muñoz-Almagro C; González-Roca E; Vergara A; Carrillo J; Juan M; Cuadras D; Noguera-Julian A; Jordan I; Alsina L
J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33497356
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 and Neutrophils: The Relationship between Hyperinflammation and Neutrophil Extracellular Traps.
Borges L; Pithon-Curi TC; Curi R; Hatanaka E
Mediators Inflamm; 2020; 2020():8829674. PubMed ID: 33343232
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients.
Olbei M; Hautefort I; Modos D; Treveil A; Poletti M; Gul L; Shannon-Lowe CD; Korcsmaros T
Front Immunol; 2021; 12():629193. PubMed ID: 33732251
[TBL] [Abstract][Full Text] [Related]
8. Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy.
Jiang Y; Rubin L; Peng T; Liu L; Xing X; Lazarovici P; Zheng W
Int J Biol Sci; 2022; 18(2):459-472. PubMed ID: 35002503
[TBL] [Abstract][Full Text] [Related]
9. Could Perturbation of Gut Microbiota Possibly Exacerbate the Severity of COVID-19
Vignesh R; Swathirajan CR; Tun ZH; Rameshkumar MR; Solomon SS; Balakrishnan P
Front Immunol; 2020; 11():607734. PubMed ID: 33569053
[No Abstract] [Full Text] [Related]
10. Editorial: Multisystem Inflammatory Syndrome in Adults (MIS-A) and the Spectrum of COVID-19.
Parums DV
Med Sci Monit; 2021 Oct; 27():e935005. PubMed ID: 34629462
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of type 1 conventional dendritic cells implicates antigen cross-presentation in multisystem inflammatory syndrome.
Huang JJ; Gaines SB; Amezcua ML; Lubell TR; Dayan PS; Dale M; Boneparth AD; Hicar MD; Winchester R; Gorelik M
J Allergy Clin Immunol; 2022 Mar; 149(3):912-922. PubMed ID: 34688775
[TBL] [Abstract][Full Text] [Related]
12. Immunology of SARS-CoV-2 infection in children.
Chou J; Thomas PG; Randolph AG
Nat Immunol; 2022 Feb; 23(2):177-185. PubMed ID: 35105983
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 multifaceted interaction with human host. Part I: What we have learnt and done so far, and the still unknown realities.
Delcuve GP; Lakowski TM; Su RC; Beacon TH; Davie JR
IUBMB Life; 2020 Nov; 72(11):2313-2330. PubMed ID: 32918855
[TBL] [Abstract][Full Text] [Related]
14. Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes.
England JT; Abdulla A; Biggs CM; Lee AYY; Hay KA; Hoiland RL; Wellington CL; Sekhon M; Jamal S; Shojania K; Chen LYC
Blood Rev; 2021 Jan; 45():100707. PubMed ID: 32425294
[TBL] [Abstract][Full Text] [Related]
15. Promising drug repurposing approach targeted for cytokine storm implicated in SARS-CoV-2 complications.
Shawki MA; Elsayed NS; Mantawy EM; Said RS
Immunopharmacol Immunotoxicol; 2021 Aug; 43(4):395-409. PubMed ID: 34057871
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
Azar MM; Shin JJ; Kang I; Landry M
Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
[TBL] [Abstract][Full Text] [Related]
17. COVID-19-associated cytokine storm syndrome and diagnostic principles: an old and new Issue.
Yongzhi X
Emerg Microbes Infect; 2021 Dec; 10(1):266-276. PubMed ID: 33522893
[TBL] [Abstract][Full Text] [Related]
18. An Impaired Inflammatory and Innate Immune Response in COVID-19.
Park SH
Mol Cells; 2021 Jun; 44(6):384-391. PubMed ID: 34098591
[TBL] [Abstract][Full Text] [Related]
19. Age-Related Differences in Immunological Responses to SARS-CoV-2.
Wong LSY; Loo EXL; Kang AYH; Lau HX; Tambyah PA; Tham EH
J Allergy Clin Immunol Pract; 2020; 8(10):3251-3258. PubMed ID: 32861856
[TBL] [Abstract][Full Text] [Related]
20. Purinergic receptor ligands: the cytokine storm attenuators, potential therapeutic agents for the treatment of COVID-19.
Zarei M; Sahebi Vaighan N; Ziai SA
Immunopharmacol Immunotoxicol; 2021 Dec; 43(6):633-643. PubMed ID: 34647511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
